Mathieu Peyrou

Experience

• 

  Large Animals Practice

  Jan 2000 - Jan 2002

  Veterinarian
• 

  Novartis

  Jun 2007 - Dec 2014

  Lead the Drug Metabolism and Pharmacokinetics group

  • Head Therapeutics Research (Animal Health)

    Apr 2012 - Dec 2014

  • Head Global Bioanalytics & DMPK manager (Animal Health)

    Jan 2012 - Apr 2012

  • Head of Bioanalytics CRA

    Jan 2010 - Dec 2011

  • DMPK Manager

    Jan 2010 - Dec 2011

  • DMPK Group Leader

    Aug 2009 - Jan 2010

  • DMPK Manager

    Jun 2007 - Jul 2009
• 

  Elanco

  Jan 2015 - Sept 2017

  • Global clinical efficacy leader

    Apr 2015 - Sept 2017

  • Head Therapeutics Research

    Jan 2015 - Mar 2015
• 

  Ceva Santé Animale

  Oct 2017 - now

  Hands-on experience on successful veterinary drug registration in Europe, US and other geographies. Change management to improve team motivation (“Autonomy, Mastery and Purpose”) and use digitalization as a lever for better performance. Strategic thinking with strong links to business, marketing and finance. Since 01 June 2018: + Test Facility Manager (GLP facility)

  • VP Global Pharmaceuticals Development

    Feb 2023 - now

  • I&D Center Leader

    Feb 2021 - Feb 2023

  • Preclinical & Clinical Development Director

    Apr 2019 - Feb 2023

  • Research and Preclinical Development Director

    Oct 2017 - Apr 2019